President Cyril Ramaphosa is on Friday launching the rollout of Lenacapavir, a new injectable prevention for HIV/Aids.

Limited supplies threaten potential positive effect of HIV prevention drug lenacapavir

Gilead Applauds Collaborative Efforts to Launch Lenacapavir for HIV Prevention in South Africa

The Presidency says Lenacapavir, a twice-yearly HIV prevention injection, will expand biomedical tools in South Africa’s fight against new infections and strengthen long-term…

President Cyril Ramaphosa is on Friday launching the rollout of Lenacapavir, a new injectable prevention for HIV/Aids.

President Cyril Ramaphosa has launched South Africa’s rollout of Lenacapavir, a twice-yearly HIV prevention injection aimed at reducing new infections and strengthening the…

A new twice-yearly HIV prevention injection could transform South Africa's fight against the epidemic — but U.S. aid cuts and limited doses threaten to slow its impact.

South Africa officially launched the national rollout of Lenacapavir, a groundbreaking, twice-yearly injectable drug for HIV prevention

South African officials on Friday announced that the HIV prevention drug Lenacapavir is now available there, calling it a "turning point."

South Africa's launch of Lenacapavir marks a transformative moment in the fight against HIV, promising to significantly reduce new infections and improve health outcomes for…

We look at how lenacapavir, a groundbreaking HIV prevention injection, is set to transform the fight against HIV and why it matters for millions worldwide.

Gauteng is set to roll out Lenacapavir, a new long-acting HIV prevention injection, targeting over 56,000 individuals at high risk of HIV infection.

A twice-yearly injectable HIV prevention drug has arrived in South Africa. The rollout of the drug, lenacapavir, is underway in the country that needs it the most, about…